Effects of cyproterone and cyproterone acetate on the adrenal gland in the rat: studies in vivo and in vitro.
Male Wistar rats were treated for three weeks with cyproterone (1.7 or 5.1 mg/day) or cyproterone acetate (2 or 6 mg/day). The adrenal weights of animals treated with either dose of cyproterone acetate were significantly less (P less than 0.001) than those of untreated animals. In contrast, the adrenal weights of animals treated with cyproterone did not differ from those of the controls. The concentrations of corticosterone in the plasma were significantly less (P less than 0.001) in both groups treated with cyproterone acetate compared with those of the controls; only the higher dose of cyproterone reduced the plasma concentration of corticosterone (P less than 0.001). Cyproterone acetate inhibited the rat adrenal 3beta-hydroxysteroid dehydrogenase-5-ene,4-ene-isomerase complex in vitro, with both pregnenolone and dehydroepiandrosterone as substrates. Analysis of the reaction rates suggested an uncompetitive mode of inhibition. These results suggest that in rats the antiandrogens cyproterone and cyproterone acetate may provoke adrenal insufficiency by inhibition of steroid biosynthesis. Furthermore, indirect evidence from the mass and morphology of the adrenal suggests that cyproterone acetate may also suppress production or secretion of ACTH by the pituitary gland.
D000311:Adrenal Glands / Q000187:drug effects* / Q000201:enzymology; D000818:Animals; D003345:Corticosterone / Q000097:blood; D003534:Cyproterone / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011374:Progesterone / Q000378:metabolism; D011375:Progesterone Reductase / Q000037:antagonists & inhibitors; D051381:Rats
D011374:Progesterone; D003534:Cyproterone; D011375:Progesterone Reductase; D003345:Corticosterone